153 related articles for article (PubMed ID: 12207808)
1. Antibodies to GAD in Japanese patients classified as Type 2 diabetes at diagnosis. High titre of GAD Ab is a predictive marker for early insulin treatment--report of west Japan (Kyushu, Yamaguchi, Osaka) study for GAD Ab(+) diabetes.
Takino H; Yamasaki H; Abiru N; Sera Y; Abe T; Kawasaki E; Yamaguchi Y; Eguchi K; Kanazawa Y; Nagataki S
Diabet Med; 2002 Sep; 19(9):730-4. PubMed ID: 12207808
[TBL] [Abstract][Full Text] [Related]
2. Clinical evaluation of non-insulin-dependent diabetes mellitus patients with autoantibodies to glutamic acid decarboxylase.
Abiru N; Takino H; Yano M; Kawasaki E; Yamasaki H; Yamaguchi Y; Akazawa S; Nagataki S
J Autoimmun; 1996 Oct; 9(5):683-8. PubMed ID: 8933285
[TBL] [Abstract][Full Text] [Related]
3. GAD 65 antibody but not ICA positivity in adult-onset diabetic patients is associated with early progression to clinical insulin dependency.
Hatziagelaki E; Jaeger C; Maeser E; Bretzel RG; Federlin K
Acta Diabetol; 1996 Dec; 33(4):291-4. PubMed ID: 9033970
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics of patients with the initial diagnosis of NIDDM with positivity for antibodies to glutamic acid decarboxylase.
Inukai T; Fujiwara Y; Tayama K; Aso Y; Ogino K; Takemura Y
Exp Clin Endocrinol Diabetes; 1997; 105(6):327-30. PubMed ID: 9439927
[TBL] [Abstract][Full Text] [Related]
5. CTLA4 gene polymorphism contributes to the mode of onset of diabetes with antiglutamic acid decarboxylase antibody in Japanese patients: genetic analysis of diabetic patients with antiglutamic acid decarboxylase antibody.
Abe T; Yamaguchi Y; Takino H; Fujita N; Yamauchi-Degawa M; Ozaki M; Yamakawa K; Sera Y; Sakamaki H; Uotani S; Kawasaki E; Awata T; Yamasaki H; Eguchi K
Diabet Med; 2001 Sep; 18(9):726-31. PubMed ID: 11606170
[TBL] [Abstract][Full Text] [Related]
6. Glutamic acid decarboxylase antibodies in non-insulin-dependent diabetes patients with secondary sulfonylurea failure in Thailand.
Rattarasarn C; Aguilar Diosdado M; Soonthornpun S
Diabetes Res Clin Pract; 1997 Sep; 37(3):193-7. PubMed ID: 9306041
[TBL] [Abstract][Full Text] [Related]
7. Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency.
Zimmet PZ; Tuomi T; Mackay IR; Rowley MJ; Knowles W; Cohen M; Lang DA
Diabet Med; 1994 Apr; 11(3):299-303. PubMed ID: 8033530
[TBL] [Abstract][Full Text] [Related]
8. Glutamic acid decarboxylase65 (GAD65) antibodies and insulin auto-antibodies in Japanese patients with non-insulin-dependent diabetes mellitus.
Maruyama T; Kasuga A; Ozawa Y; Nagata A; Abiko F; Suzuki Y; Saruta T
Endocr J; 1997 Feb; 44(1):43-51. PubMed ID: 9152613
[TBL] [Abstract][Full Text] [Related]
9. [Glutamic acid decarboxylase and tyrosine phosphatase-like IA-2 antibodies for diabetes classification in unselected diabetic patients].
Reinsch B; Zimmy S; Schatz H; Pfohl M
Med Klin (Munich); 2003 Feb; 98(2):67-71. PubMed ID: 12601530
[TBL] [Abstract][Full Text] [Related]
10. GAD antibodies seldom disappear in slowly progressive IDDM.
Kobayashi T; Nakanishi K; Okubo M; Murase T; Kosaka K
Diabetes Care; 1996 Sep; 19(9):1031. PubMed ID: 8875105
[No Abstract] [Full Text] [Related]
11. Distribution of autoantibodies to glutamic acid decarboxylase across the spectrum of diabetes mellitus seen in South Africa.
Panz VR; Kalk WJ; Zouvanis M; Joffe BI
Diabet Med; 2000 Jul; 17(7):524-7. PubMed ID: 10972582
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to glutamic acid decarboxylase in Japanese diabetic patients with secondary failure of oral hypoglycaemic therapy.
Fukui M; Nakano K; Shigeta H; Yoshimori K; Fujii M; Kitagawa Y; Mori H; Kajiyama S; Nakamura N; Abe N; Obayashi H; Fukui I; Ohta K; Ohta M; Kondo M
Diabet Med; 1997 Feb; 14(2):148-52. PubMed ID: 9047093
[TBL] [Abstract][Full Text] [Related]
13. Clinical and genetic characteristics of diabetic patients with high-titer (>10,000 U/ml) of antibodies to glutamic acid decarboxylase.
Ishii M; Hasegawa G; Fukui M; Obayashi H; Ohta M; Ogata M; Yoshioka K; Kitagawa Y; Nakano K; Yoshikawa T; Nakamura N
Immunol Lett; 2005 Jul; 99(2):180-5. PubMed ID: 16009268
[TBL] [Abstract][Full Text] [Related]
14. Associations of anti-GAD antibodies with islet cell antibodies and insulin autoantibodies in first-degree relatives of type I diabetic patients.
Roll U; Christie MR; Standl E; Ziegler AG
Diabetes; 1994 Jan; 43(1):154-60. PubMed ID: 8262311
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease.
Tuomilehto J; Zimmet P; Mackay IR; Koskela P; Vidgren G; Toivanen L; Tuomilehto-Wolf E; Kohtamäki K; Stengård J; Rowley MJ
Lancet; 1994 Jun; 343(8910):1383-5. PubMed ID: 7910881
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and clinical characteristics of insulin-treated, anti-GAD-positive, type 2 diabetic subjects in an outpatient clinical department of a Dutch teaching hospital.
Römkens TE; Kusters GC; Netea MG; Netten PM
Neth J Med; 2006 Apr; 64(4):114-8. PubMed ID: 16609158
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to GAD in Japanese diabetic patients: a multicenter study.
Tsuruoka A; Matsuba I; Toyota T; Isshiki G; Nagataki S; Ikeda Y
Diabetes Res Clin Pract; 1995 Jun; 28(3):191-9. PubMed ID: 8529498
[TBL] [Abstract][Full Text] [Related]
18. [When and why should anti-GAD antibodies by looked for in the non-insulin-dependent diabetic patient?].
Atlan-Gepner C; Vialettes B
Diabetes Metab; 1999 Jun; 25(2):177-9. PubMed ID: 10443330
[No Abstract] [Full Text] [Related]
19. Clinical evaluation of a radioimmunoprecipitation assay for IA-2 antibody and comparison of GAD antibody in type 1 diabetes mellitus.
Ohta M; Ohta K; Obayashi H; Nakamura N; Shigeta H; Nakano K; Hasegawa G; Fukui M; Kitagawa Y; Nishimura M; Itoh N
Autoimmunity; 2000 Sep; 32(2):79-88. PubMed ID: 11078153
[TBL] [Abstract][Full Text] [Related]
20. Clinical and Genetic Characteristics of Non-Insulin-Requiring Glutamic Acid Decarboxylase (GAD) Autoantibody-Positive Diabetes: A Nationwide Survey in Japan.
Yasui J; Kawasaki E; Tanaka S; Awata T; Ikegami H; Imagawa A; Uchigata Y; Osawa H; Kajio H; Kawabata Y; Shimada A; Takahashi K; Yasuda K; Yasuda H; Hanafusa T; Kobayashi T;
PLoS One; 2016; 11(5):e0155643. PubMed ID: 27177031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
